Health Affairs, 24, no. 3 (2005): 631-634 doi: 10.1377/hlthaff.24.3.631 © 2005 by Project HOPE	New Online   Pay Cuts For Medicare Docs   Access To Care Woes   Public Coverage More Efficient   Empowering Consumers

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Plotkin, S. A. Search for Related Content PubMed PubMed Citation Articles by Plotkin, S. A. Related Collections Consumer Issues Health Promotion/Disease Prevention International Issues Vaccines Pharmaceuticals Public Health Research And Technology

Infrastructure

PERSPECTIVE

Why Certain Vaccines Have Been Delayed Or Not Developed At All

Vaccine development is a long process, with the time from early research to licensure steadily increasing. At one time the process took about ten years; now it takes closer to fifteen to twenty years. The process begins with investigators in universities or biotech firms who have an idea. However, to take things further, there must be a vaccine manufacturer, a regulatory authority ready to give permission for the use of the vaccine, and public health authorities that will recommend and foster vaccination.

                      What's this?